Review of Whether Strategic Shareholdings Should Be Retained and Their Sale
First written in FY2022. 2 of 3 entries say "Advanced", first in FY2023. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「During the fiscal year, we newly acquired shares in 4 unlisted companies and sold shares in 1 company other than an unlisted company. The total acquisition cost of the unlisted shares was ¥172.56 million, and the total sale price of the shares other than unlisted shares was ¥252.701 million.」
For cross-shareholdings, while continuing the policy of reviewing whether holdings remain appropriate, we sold shares in 1 listed company for ¥252.701 million and newly acquired shares in 4 unlisted companies. - FY2023AdvancedAnnual report
「Based on the Board of Directors' review of the appropriateness of individual holdings, we sold shares in 1 company during the fiscal year.」
For cross-shareholdings, annual reviews based on business relationships, profitability, cost of capital and other factors continued, and shares in 1 company were sold for ¥12.5 million during the fiscal year. - FY2022First statedAnnual report
「Each year, the Board of Directors and other bodies review whether holdings remain appropriate based on such factors as whether the holdings contribute to maintaining and strengthening relationships with business partners, whether dividend income and income from related transactions are commensurate with our cost of capital, and whether assets are being used inefficiently based on the proportion of the shareholding balance to our net assets. Based on the Board of Directors' review of the appropriateness of individual holdings, we sold shares in 2 companies during the fiscal year.」
For cross-shareholdings, the policy and results of conducting annual reviews based on business relationships, profitability, cost of capital and the ratio to net assets, and selling shares in 2 companies during the fiscal year, were disclosed for the first time.